J Korean Med Sci.  2020 Dec;35(47):e412. 10.3346/jkms.2020.35.e412.

Antimicrobial Consumption as a Key Component of Antimicrobial Stewardship Programs: a Meaningful Movement toward Evidence-based Antimicrobial Stewardship of Validated Outcome Measures

• Yoon YK

• KMID: 2509448
• DOI: http://doi.org/10.3346/jkms.2020.35.e412

Reference

1. Kim B, Myung R, Lee M, Kim J, Pai H. Trend of antibiotic usage for hospitalized community-acquired pneumonia cases in Korea based on the 2010–2015 ational Health Insurance Data. J Korean Med Sci. 2020; 35(47):e390.

2. Ryu S. The new Korean action plan for containment of antimicrobial resistance. J Glob Antimicrob Resist. 2017; 8:70–73. PMID: 28024981.

3. Johnson AP, Muller-Pebody B, Budd E, Ashiru-Oredope D, Ladenheim D, Hain D, et al. Improving feedback of surveillance data on antimicrobial consumption, resistance and stewardship in England: putting the data at your Fingertips. J Antimicrob Chemother. 2017; 72(4):953–956. PMID: 27999049.

4. Polk RE, Fox C, Mahoney A, Letcavage J, MacDougall C. Measurement of adult antibacterial drug use in 130 US hospitals: comparison of defined daily dose and days of therapy. Clin Infect Dis. 2007; 44(5):664–670. PMID: 17278056.

5. Yun JM, Shin DW, Hwang SS, Cho J, Nam YS, Kim JH, et al. Effect of public disclosure on antibiotic prescription rate for upper respiratory tract infections. JAMA Intern Med. 2015; 175(3):445–447. PMID: 25506784.

6. Kim ES, Park SW, Lee CS, Kwak YG, Moon C, Kim BN. Impact of a national hospital evaluation program using clinical performance indicators on the use of surgical antibiotic prophylaxis in Korea. Int J Infect Dis. 2012; 16(3):e187–e192. PMID: 22245171.